Iceland· IS-EU/1/06/357/001-002 & 018
Gardasil
A humaner papillomvirus (typen 6, 11, 16, 18, 31, 33, 45, 52, 58) product, registered in Iceland by Merck Sharp & Dohme B.V.*. The same ATC class is registered in 10 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Humaner papillomvirus (typen 6, 11, 16, 18, 31, 33, 45, 52, 58) is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BM03 (humaner papillomvirus (typen 6, 11, 16, 18, 31, 33, 45, 52, 58)), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Humaner papillomvirus (typen 6, 11, 16, 18, 31, 33, 45, 52, 58) · ATC J07BM03
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Manufacturer
- Merck Sharp & Dohme B.V.*
- Country
- Iceland (IS)
- ATC code
- J07BM03
- ATC class
- Humaner Papillomvirus (Typen 6, 11, 16, 18, 31, 33, 45, 52, 58)
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BM03
Humaner papillomvirus (typen 6, 11, 16, 18, 31, 33, 45, 52, 58), as other registers publish it.
- IcelandGardasil 9Merck Sharp & Dohme B.V.*
- NorwayGardasil 9Orifarm AS
- FinlandGardasil 9Merck Sharp & Dohme B.V.
- FinlandGardasil 9Merck Sharp & Dohme B.V.
- PolandGardasil 9Merck Sharp & Dohme B.V.
- BelgiumGardasil 9Merck Sharp & Dohme
- FinlandGardasil 9Merck Sharp & Dohme B.V.
- NorwayGardasil 9Merck Sharp & Dohme B.V
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/503f9015-5695-46d4-b163-9a4b5b4280e3 GET /v1/drugs/503f9015-5695-46d4-b163-9a4b5b4280e3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, dreifa",
"source": "lyfjastofnun",
"atc_raw": "J07BM03",
"marketed": false,
"strength": null,
"ma_number": "EU/1/06/357/001-002 & 018",
"substance": "Mannapapillomaveira af gerð 6 L1 prótein,Mannapapillomaveira af gerð 11 L1 prótein,Mannapapillomaveira af gerð 16 L1 prótein,Mannapapillomaveira af gerð 18 L1 prótein,Mannapipillomaveira af gerð 31 L1 prótein,Mannapapillomaveira af gerð 33 L1 prótein,Mannapapillomaveira af gerð 45 L1 prótein,Mannapapillomaveira af gerð 52 L1 prótein,Mannapapillomaveira af gerð 58 L1 prótein",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "39007"
}See everything about humaner papillomvirus (typen 6, 11, 16, 18, 31, 33, 45, 52, 58).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.